# Sensing Using Neutrophil Activation Probe on the Intensive Therapy Unit

> **NCT02804854** · PHASE2 · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 11 (actual)

## Conditions studied

- Lung Disease

## Interventions

- **DRUG:** Neutrophil Activation Probe (NAP)

## Key facts

- **NCT ID:** NCT02804854
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2022-07
- **Final completion:** 2022-07
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2022-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02804854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02804854, "Sensing Using Neutrophil Activation Probe on the Intensive Therapy Unit". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02804854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*